Cost-effectiveness of Treating All HBV+ Individuals in the U.S. Cost-effectiveness of Treating All HBV+ Individuals in the U.S.

This analysis suggests that expanding efforts to diagnose and treat individuals chronically infected with HBV would be cost-effective and provide a positive return on investment.Journal of Viral Hepatitis
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news